Biogen Idec (BIIB) Reports In-Line Q4; Guides
Tweet Send to a Friend
Biogen Idec (Nasdaq: BIIB) reports Q4 EPS of $0.93 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
